Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin
- 28 February 2002
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 36 (2), 271-277
- https://doi.org/10.1016/s0168-8278(01)00243-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosisJournal of Hepatology, 1999
- Genetic control of the circulating concentration of transforming growth factor type beta1Human Molecular Genetics, 1999
- GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-??1 GENETransplantation, 1998
- Association of a Polymorphism of the Transforming Growth Factor-β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese WomenJournal of Bone and Mineral Research, 1998
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Chronic hepatitis C: T-helperl/T-helper2 imbalance could cause virus persistence in peripheral bloodScandinavian Journal of Clinical and Laboratory Investigation, 1997
- Intrahepatic expression of pro‐inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis CLiver International, 1996
- Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood PressureHypertension, 1996
- Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfaHepatology, 1996